Increased investment in thoracic surgical expertise increased UK lung cancer resection rate

Increased investment in specialist thoracic surgical expertise can lead to a significant rise in the lung cancer resection rate, based on data from England between 2008 and 2009 that was presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer (IASLC).

In England, resection is less common than in other countries, and is performed by
both cardiothoracic and pure thoracic surgeons. Researchers tested the that resection rate was related to the caseload and local provision of pure thoracic surgeons, and that expansion of thoracic surgery could increase the resection rate.

In 2008, 31 units provided the thoracic surgery service to 33 cancer networks comprising 174 trusts. Of these, 13 units (42%) had two or more pure thoracic surgeons. In 2009 this grew to 18 units (58%).

In 2008, there were 15,774 recorded cases of confirmed non-small cell lung cancer (NSCLC). Of these, 2,240 (14.2%) patients underwent surgical resection. In 2009, following the new consultant appointments, the number of histologically confirmed NSCLC increased by 13.8%, from 15,774 to 17,948 cases. The overall resection rate increased by 46% (from 14.2% to 20.7%).

In trusts where a pure thoracic surgeon was present in more than two-thirds of the lung cancer multidisciplinary team meetings, the NSCLC resection rate was significantly higher than those with lower attendance (median 14.7% vs 11.7%). Networks that experienced an expansion in their number of pure thoracic surgeons during this period experienced a significant and larger increase in resection rate than those who did not (median 66.3% vs 19%).

Provided by International Association for the Study of Lung Cancer
Citation: Increased investment in thoracic surgical expertise increased UK lung cancer resection rate (2011, July 6) retrieved 19 April 2024 from https://medicalxpress.com/news/2011-07-investment-thoracic-surgical-expertise-uk.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Research defines timeframes, factors to deem early stage lung cancer cured

 shares

Feedback to editors